Vivani Medical, Inc. (VANI) News
Follow Vivani Medical, Inc. (VANI) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 7 public stories across 6 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Vivani Medical plans participation in upcoming investor conferences
Vivani Medical said it plans to participate in upcoming investor conferences, as part of company outreach.
EQUITY | Sep 03, 2026, 08:17 PM UTC
L
VANI - Vivani Medical Announces Participation in Upcoming Investor Conferences
VANI - Vivani Medical Announces Participation in Upcoming Investor Conferences
EQUITY | Sep 03, 2026, 08:08 PM UTC
L
Vivani Medical reports Q2 2026 financial results and business update
Vivani Medical (VANI) reports its second quarter 2026 financial results and provides a business update, according to the TradeXchange Newsdesk.
EARNINGS | Aug 13, 2026, 08:06 PM UTC
M
Vivani Medical Completes Dosing In Phase 1 Trial
Vivani Medical completes dosing in phase 1 trial for weight management
EQUITY | Aug 06, 2026, 12:02 PM UTC
H
ClearOne To Acquire Vivani Medical Subsidiary Cortigent For 12.5M Shares Of CLRO Worth ~$40.4M; ClearOne To File S-1 Seeking To Raise $10M-$
Vivani Medical, Inc. (NASDAQ: VANI ) ("Vivani"), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, announced today that it has entered into a definitive agreement and plan
MNA | Jul 02, 2026, 12:03 PM UTC
M
VANI Receives Approval
Vivani Medical receives regulatory approval for a Phase 1 clinical trial of NPM-139 Semaglutide Implant
EQUITY | Jun 25, 2026, 11:30 AM UTC
L
VANI: CEO to Present at BIO
Vivani Medical CEO Adam Mendelsohn to present at the 2026 BIO International Convention
EARNINGS | Jun 22, 2026, 08:03 PM UTC